Concord Asset Management LLC VA Buys 604 Shares of Intuitive Surgical, Inc. $ISRG

Concord Asset Management LLC VA grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.7% in the second quarter, HoldingsChannel.com reports. The firm owned 3,517 shares of the medical equipment provider’s stock after purchasing an additional 604 shares during the period. Concord Asset Management LLC VA’s holdings in Intuitive Surgical were worth $1,911,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Invesco Ltd. increased its holdings in Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after purchasing an additional 71,794 shares in the last quarter. Northern Trust Corp increased its holdings in Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after purchasing an additional 11,988 shares in the last quarter. Wellington Management Group LLP increased its holdings in Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Nuveen LLC bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $1,715,899,000. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have commented on ISRG. The Goldman Sachs Group decreased their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday, October 1st. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday, October 8th. UBS Group boosted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 4th. Finally, Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $589.43.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 3.2%

Intuitive Surgical stock opened at $429.59 on Monday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The business’s 50 day simple moving average is $458.68 and its 200 day simple moving average is $497.84. The company has a market cap of $154.00 billion, a price-to-earnings ratio of 59.91, a PEG ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.78 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.